Guochao Liao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Respiratory Syndrome Coronavirus

Childhood Cancer

Top Venues

Journal of medicinal chemistry

RSC medicinal chemistry

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Deying Yang, Xiaohui Li, Jinmei Li, Zichun Liu, Tongtong Li, Pan Liao, Xiang Luo, Zhongqiu Liu, Wenbo Ming, Guochao Liao
Fully Synthetic TF-Based Self-Adjuvanting Vaccine Simultaneously Triggers iNKT Cells and Mincle and Protects Mice against Tumor Development. Journal of medicinal chemistry (2024)
Lingqiang Gao, Guiqi Li, Cuiping Qiu, Yifan Ye, Xiaohui Li, Pan Liao, Wenbo Ming, Zhongqiu Liu, Xiang Luo, Guochao Liao
Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant. Journal of medicinal chemistry (2024)
Lingqiang Gao, Guiqi Li, Cuiping Qiu, Yifan Ye, Xiaohui Li, Pan Liao, Wenbo Ming, Zhongqiu Liu, Xiang Luo, Guochao Liao
Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant. Journal of medicinal chemistry 67 (12) (2024)
Lingqiang Gao, Guiqi Li, Cuiping Qiu, Yifan Ye, Xiaohui Li, Pan Liao, Wenbo Ming, Zhongqiu Liu, Xiang Luo, Guochao Liao
Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant. Journal of medicinal chemistry 67 (12) (2024)
Shiwei Su, Liqing Chen, Menglan Yang, Dan Liang, Bixia Ke, Zhongqiu Liu, Changwen Ke, Guochao Liao, Liang Liu, Xiang Luo
Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine. RSC medicinal chemistry 14 (1) (2022)
Shiwei Su, Liqing Chen, Menglan Yang, Dan Liang, Bixia Ke, Zhongqiu Liu, Changwen Ke, Guochao Liao, Liang Liu, Xiang Luo
Design, synthesis and immunological evaluation of monophosphoryl lipid A derivatives as adjuvants for a RBD-hFc based SARS-CoV-2 vaccine. RSC medicinal chemistry 14 (1) (2022)
Xiang Luo, Qinghai Lian, Wenwei Li, Liqing Chen, Renyu Zhang, Deying Yang, Lingqiang Gao, Xiaoxiao Qi, Zhongqiu Liu, Guochao Liao
Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development. Chemical science 12 (48) (2021)